Porcilis APP contains toxoids produced by Actinobacillus pleuropneumoniae and can be used to immunise pigs against pleuropneumonia. Its use may contribute to the reduction of antimicrobial use.
Suspension for injection
Per 2 ml dose:
- 600 mg Actinobacillus pleuropneumoniae antigen concentrate containing:
- OMP [outer membrane protein] 50 units*
- Apx I toxoid 50 units
- Apx II toxoid 50 units
- Apx III toxoid 50 units
* Units relative to an internal standard determined to be efficacious in pigs
Indications for use
Porcilis APP is for the active immunisation of weaned piglets to reduce mortality, clinical signs and lesions of pleuropneumonia caused by Actinobacillus pleuropneumoniae.
Onset of immunity: 2 weeks after completion of the vaccination scheme.
Duration of immunity: 11 weeks after completion of the vaccination scheme.
Pigs – meat 0 days
1 glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 100 ml (50 doses).
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018